| Filed | As-Of/On | Form | Fullname | Fund Class | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypotheticals Return |
Hypotheticals Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-20 | 2009-09-30 | 13F-HR | Great Northern Asset Management Inc | Institution | | Sold All | -164,675 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Great Northern Asset Management Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-20 | 2009-09-30 | N-Q | Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund | Small-Cap Core | | Sold All | -301,607 | -100 % | | | | 0.00 % | $0 | | | | | | News Article | History of Oppenheimer Main Street Small Cap Fund - Oppenheimer Main Street Small Cap Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-19 | 2009-09-30 | 13F-HR/A | Royal Bank Of Canada | Institution | 3,000 | No Change | 0 | 0 % | $31,170 | $30,960 | $-210 | -0.67 % | $0 | | | | | | News Article | History of Royal Bank Of Canada Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | N-Q | Mutual Of America Institutional Funds Inc - Small Cap Growth Fund | Small-Cap Growth | 6,045 | No Compare | | | $61,961 | $62,384 | $423 | 0.68 % | | | | | | | News Article | History of Mutual Of America Institutional Funds Inc - Small Cap Growth Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | N-Q | Mutual Of America Institutional Funds Inc - Small Cap Value Fund | Small-Cap Value | 9,015 | No Compare | | | $92,404 | $93,035 | $631 | 0.68 % | | | | | | | News Article | History of Mutual Of America Institutional Funds Inc - Small Cap Value Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | N-Q | Mutual Of America Investment Corp - Small Cap Growth Fund | Small-Cap Growth | 313,373 | No Compare | | | $3,212,073 | $3,234,009 | $21,936 | 0.68 % | | | | | | | News Article | History of Mutual Of America Investment Corp - Small Cap Growth Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-18 | 2009-09-30 | N-Q | Mutual Of America Investment Corp - Small Cap Value Fund | Small-Cap Value | 440,855 | Added More | 114,845 | 35.22 % | $4,518,764 | $4,549,624 | $30,860 | 0.68 % | $8,039 | | | | | | News Article | History of Mutual Of America Investment Corp - Small Cap Value Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Amvescap Plc | Institution | 1,057,083 | Added More | 191,538 | 22.12 % | $10,634,255 | $10,909,097 | $274,842 | 2.58 % | $49,800 | | | | | | News Article | History of Amvescap Plc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR/A | Credit Suisse First Boston | Institution | 19,468 | Sold Some | -54,328 | -73.61 % | $195,848 | $200,910 | $5,062 | 2.58 % | $-14,125 | | | | | | News Article | History of Credit Suisse First Boston Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Rothschild Asset Management Inc | Institution | 712,929 | Sold Some | -28,256 | -3.81 % | $7,172,066 | $7,357,427 | $185,362 | 2.58 % | $-7,347 | | | | | | News Article | History of Rothschild Asset Management Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-17 | 2009-09-30 | 13F-HR | Wells Fargo And Co | Institution | 56,419 | Sold Some | -9,772 | -14.76 % | $567,575 | $582,244 | $14,669 | 2.58 % | $-2,541 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | American International Group Inc | Institution | 36,676 | No Change | 0 | 0 % | $372,628 | $378,496 | $5,868 | 1.57 % | $0 | | | | | | News Article | History of American International Group Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Aqr Capital Management Llc | Institution | 22,700 | New Holding | 22,700 | 100 % | $230,632 | $234,264 | $3,632 | 1.57 % | $3,632 | | | | | | News Article | History of Aqr Capital Management Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bam Management Llc | No Data | 12,395 | New Holding | 12,395 | 100 % | $125,933 | $127,916 | $1,983 | 1.57 % | $1,983 | | | | | | News Article | History of Bam Management Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Bogle Investment Management L P | Institution | 172,693 | New Holding | 172,693 | 100 % | $1,754,561 | $1,782,192 | $27,631 | 1.57 % | $27,631 | | | | | | News Article | History of Bogle Investment Management L P Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Citadel L P | Institution | 35,317 | Added More | 35,282 | 100805.71 % | $358,821 | $364,471 | $5,651 | 1.57 % | $5,645 | | | | | | News Article | History of Citadel L P Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Fmr Corp | Institution | 120,400 | No Change | 0 | 0 % | $1,223,264 | $1,242,528 | $19,264 | 1.57 % | $0 | | | | | | News Article | History of Fmr Corp Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Icahn Capital Lp | Institution | 2,816,861 | No Change | 0 | 0 % | $28,619,308 | $29,070,006 | $450,698 | 1.57 % | $0 | | | | | | News Article | History of Icahn Capital Lp Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Icahn Carl C Et Al | Institution | 704,214 | No Change | 0 | 0 % | $7,154,814 | $7,267,488 | $112,674 | 1.57 % | $0 | | | | | | News Article | History of Icahn Carl C Et Al Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Ing Groep Nv | Institution | 18,550 | Added More | 3,200 | 20.84 % | $188,468 | $191,436 | $2,968 | 1.57 % | $512 | | | | | | News Article | History of Ing Groep Nv Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Kingdon Capital Management Llc | Institution | 1,000,000 | Sold Some | -402,237 | -28.68 % | $10,160,000 | $10,320,000 | $160,000 | 1.57 % | $-64,358 | | | | | | News Article | History of Kingdon Capital Management Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Loeb Arbitrage Management Inc | Institution | 160,885 | Added More | 6,130 | 3.96 % | $1,634,592 | $1,660,333 | $25,742 | 1.57 % | $981 | | | | | | News Article | History of Loeb Arbitrage Management Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Madison Square Investors Llc | No Data | 8,065 | Sold Some | -55,399 | -87.29 % | $81,940 | $83,231 | $1,290 | 1.57 % | $-8,864 | | | | | | News Article | History of Madison Square Investors Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Millennium Management Llc | Institution | 2,113,000 | Added More | 556,981 | 35.79 % | $21,468,080 | $21,806,160 | $338,080 | 1.57 % | $89,117 | | | | | | News Article | History of Millennium Management Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Morgan Stanley | Institution | 349,931 | Added More | 247,555 | 241.80 % | $3,555,299 | $3,611,288 | $55,989 | 1.57 % | $39,609 | | | | | | News Article | History of Morgan Stanley Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | New Mountain Vantage Advisers L L C | Institution | 557,631 | New Holding | 557,631 | 100 % | $5,665,531 | $5,754,752 | $89,221 | 1.57 % | $89,221 | | | | | | News Article | History of New Mountain Vantage Advisers L L C Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | New York State Teachers Retirement System | Institution | 1,280,920 | New Holding | 1,280,920 | 100 % | $13,014,147 | $13,219,094 | $204,947 | 1.57 % | $204,947 | | | | | | News Article | History of New York State Teachers Retirement System Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Northern Trust Corp | Institution | 658,567 | Added More | 59,138 | 9.86 % | $6,691,041 | $6,796,411 | $105,371 | 1.57 % | $9,462 | | | | | | News Article | History of Northern Trust Corp Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR/A | Oppenheimer Funds Inc | Institution | 1,200 | Sold Some | -472,817 | -99.74 % | $12,192 | $12,384 | $192 | 1.57 % | $-75,651 | | | | | | News Article | History of Oppenheimer Funds Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Oss Capital Management | Institution | 1,000,000 | Sold Some | -234,200 | -18.97 % | $10,160,000 | $10,320,000 | $160,000 | 1.57 % | $-37,472 | | | | | | News Article | History of Oss Capital Management Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Shaw D E And Co Inc | Institution | 683,446 | Added More | 445,276 | 186.95 % | $6,943,811 | $7,053,163 | $109,351 | 1.57 % | $71,244 | | | | | | News Article | History of Shaw D E And Co Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Soros Fund Management Llc | Institution | 15,800 | New Holding | 15,800 | 100 % | $160,528 | $163,056 | $2,528 | 1.57 % | $2,528 | | | | | | News Article | History of Soros Fund Management Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Two Sigma Investments Llc | Institution | 179,711 | Added More | 102,400 | 132.45 % | $1,825,864 | $1,854,618 | $28,754 | 1.57 % | $16,384 | | | | | | News Article | History of Two Sigma Investments Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Us Bancorp De | Institution | 3,257 | No Change | 0 | 0 % | $33,091 | $33,612 | $521 | 1.57 % | $0 | | | | | | News Article | History of Us Bancorp De Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Visium Asset Management Llc | Institution | 30,000 | New Holding | 30,000 | 100 % | $304,800 | $309,600 | $4,800 | 1.57 % | $4,800 | | | | | | News Article | History of Visium Asset Management Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-09-30 | 13F-HR | Weiss Multi-Strategy Advisers Llc | Institution | 10,000 | New Holding | 10,000 | 100 % | $101,600 | $103,200 | $1,600 | 1.57 % | $1,600 | | | | | | News Article | History of Weiss Multi-Strategy Advisers Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-16 | 2009-06-30 | 13F-HR/A | Highland Capital Management Lp | Institution | | Sold All | -216,356 | -100 % | | | | 1.57 % | $-34,617 | | | | | | News Article | History of Highland Capital Management Lp Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Ameriprise Financial Inc | Institution | | Sold All | -17,040 | -100 % | | | | 4.45 % | $-7,498 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Axa | Institution | 73,723 | Sold Some | -267,484 | -78.39 % | $728,383 | $760,821 | $32,438 | 4.45 % | $-117,693 | | | | | | News Article | History of Axa Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Barclays Plc | Institution | 72,075 | Added More | 18,439 | 34.37 % | $712,101 | $743,814 | $31,713 | 4.45 % | $8,113 | | | | | | News Article | History of Barclays Plc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Batterymarch Financial Management Inc | Institution | 350,590 | Sold Some | -1,280 | -0.36 % | $3,463,829 | $3,618,089 | $154,260 | 4.45 % | $-563 | | | | | | News Article | History of Batterymarch Financial Management Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Bnp Paribas Arbitrage Sa | Institution | 17,284 | New Holding | 17,284 | 100 % | $170,766 | $178,371 | $7,605 | 4.45 % | $7,605 | | | | | | News Article | History of Bnp Paribas Arbitrage Sa Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Cambridge Trust Co | Institution | 12,519 | Sold Some | -2,500 | -16.64 % | $123,688 | $129,196 | $5,508 | 4.45 % | $-1,100 | | | | | | News Article | History of Cambridge Trust Co Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Credit Agricole S A | Institution | 8,885 | Added More | 680 | 8.28 % | $87,784 | $91,693 | $3,909 | 4.45 % | $299 | | | | | | News Article | History of Credit Agricole S A Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | First Mercantile Trust Co | Institution | 650 | New Holding | 650 | 100 % | $6,422 | $6,708 | $286 | 4.45 % | $286 | | | | | | News Article | History of First Mercantile Trust Co Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Gartmore Mutual Fund Capital Trust | Institution | 313 | Sold Some | -38,598 | -99.19 % | $3,092 | $3,230 | $138 | 4.45 % | $-16,983 | | | | | | News Article | History of Gartmore Mutual Fund Capital Trust Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geduld E E | Institution | | Sold All | -20,000 | -100 % | | | | 4.45 % | $-8,800 | | | | | | News Article | History of Geduld E E Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Geode Capital Management Llc | Institution | 166,061 | Added More | 24,839 | 17.58 % | $1,640,683 | $1,713,750 | $73,067 | 4.45 % | $10,929 | | | | | | News Article | History of Geode Capital Management Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Goldman Sachs Group Inc | Institution | 484,389 | Sold Some | -164,979 | -25.40 % | $4,785,763 | $4,998,894 | $213,131 | 4.45 % | $-72,591 | | | | | | News Article | History of Goldman Sachs Group Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Knight Capital Group Inc | Institution | 43,039 | New Holding | 43,039 | 100 % | $425,225 | $444,162 | $18,937 | 4.45 % | $18,937 | | | | | | News Article | History of Knight Capital Group Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Los Angeles Capital Management And Equity Research Inc | Institution | 24,900 | New Holding | 24,900 | 100 % | $246,012 | $256,968 | $10,956 | 4.45 % | $10,956 | | | | | | News Article | History of Los Angeles Capital Management And Equity Research Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Martingale Asset Management L P | Institution | 42,608 | Sold Some | -25,700 | -37.62 % | $420,967 | $439,715 | $18,748 | 4.45 % | $-11,308 | | | | | | News Article | History of Martingale Asset Management L P Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Neuberger Berman Group Llc | No Data | | Sold All | -33,500 | -100 % | | | | 4.45 % | $-14,740 | | | | | | News Article | History of Neuberger Berman Group Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | New York State Common Retirement Fund | Institution | 54,800 | No Change | 0 | 0 % | $541,424 | $565,536 | $24,112 | 4.45 % | $0 | | | | | | News Article | History of New York State Common Retirement Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Oak Hill Platinum Partners Llc | Institution | 13,085 | Sold Some | -16,191 | -55.30 % | $129,280 | $135,037 | $5,757 | 4.45 % | $-7,124 | | | | | | News Article | History of Oak Hill Platinum Partners Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Oppenheimer And Co Inc | Institution | 10,776 | Added More | 1 | 0.00 % | $106,467 | $111,208 | $4,741 | 4.45 % | $0 | | | | | | News Article | History of Oppenheimer And Co Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Panagora Asset Management Inc | Institution | 23,443 | Added More | 20,743 | 768.25 % | $231,617 | $241,932 | $10,315 | 4.45 % | $9,127 | | | | | | News Article | History of Panagora Asset Management Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Pergamon Offshore Advisors L P | Institution | 11,416 | Sold Some | -96,797 | -89.45 % | $112,790 | $117,813 | $5,023 | 4.45 % | $-42,591 | | | | | | News Article | History of Pergamon Offshore Advisors L P Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Price Michael F | Institution | 240,000 | Added More | 89,900 | 59.89 % | $2,371,200 | $2,476,800 | $105,600 | 4.45 % | $39,556 | | | | | | News Article | History of Price Michael F Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Capital Markets Arbitrage S A | Institution | | Sold All | -3,211 | -100 % | | | | 4.45 % | $-1,413 | | | | | | News Article | History of Rbc Capital Markets Arbitrage S A Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Rbc Dain Rauscher Inc | Institution | 8,119 | Added More | 7,199 | 782.50 % | $80,216 | $83,788 | $3,572 | 4.45 % | $3,168 | | | | | | News Article | History of Rbc Dain Rauscher Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Renaissance Technologies Corp | Institution | 3,149,084 | Sold Some | -62,000 | -1.93 % | $31,112,950 | $32,498,547 | $1,385,597 | 4.45 % | $-27,280 | | | | | | News Article | History of Renaissance Technologies Corp Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR/A | Research Affiliates Llc | Institution | 11,511 | No Change | 0 | 0 % | $113,729 | $118,794 | $5,065 | 4.45 % | $0 | | | | | | News Article | History of Research Affiliates Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Sg Americas Securities Llc | Institution | 12,645 | New Holding | 12,645 | 100 % | $124,933 | $130,496 | $5,564 | 4.45 % | $5,564 | | | | | | News Article | History of Sg Americas Securities Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Spark Lp | Institution | 79,900 | Sold Some | -18,400 | -18.71 % | $789,412 | $824,568 | $35,156 | 4.45 % | $-8,096 | | | | | | News Article | History of Spark Lp Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Vanguard Group Inc | Institution | 2,084,130 | Sold Some | -24,148 | -1.14 % | $20,591,204 | $21,508,222 | $917,017 | 4.45 % | $-10,625 | | | | | | News Article | History of Vanguard Group Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-13 | 2009-09-30 | 13F-HR | Williams Jones And Associates Inc | Institution | 15,933 | No Change | 0 | 0 % | $157,418 | $164,429 | $7,011 | 4.45 % | $0 | | | | | | News Article | History of Williams Jones And Associates Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Arnhold And S Bleichroeder Advisers Llc | Institution | 1,213,387 | Added More | 47,120 | 4.04 % | $12,048,933 | $12,522,154 | $473,221 | 3.92 % | $18,377 | | | | | | News Article | History of Arnhold And S Bleichroeder Advisers Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 3,240,124 | Added More | 223,448 | 7.40 % | $32,174,431 | $33,438,080 | $1,263,648 | 3.92 % | $87,145 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Barclays Global Investors Uk Holdings Ltd | Institution | 3,240,124 | Added More | 110,883 | 3.54 % | $32,174,431 | $33,438,080 | $1,263,648 | 3.92 % | $43,244 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Baupost Group Llc | Institution | 2,071,382 | New Holding | 2,071,382 | 100 % | $20,568,823 | $21,376,662 | $807,839 | 3.92 % | $807,839 | | | | | | News Article | History of Baupost Group Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Canada Pension Plan Investment Board | Institution | 5,800 | No Change | 0 | 0 % | $57,594 | $59,856 | $2,262 | 3.92 % | $0 | | | | | | News Article | History of Canada Pension Plan Investment Board Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Chicago Equity Partners Llc | Institution | | Sold All | -107,175 | -100 % | | | | 3.92 % | $-41,798 | | | | | | News Article | History of Chicago Equity Partners Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Credit Suisse | Institution | 13,137 | New Holding | 13,137 | 100 % | $130,450 | $135,574 | $5,123 | 3.92 % | $5,123 | | | | | | News Article | History of Credit Suisse Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Dellacamera Capital Management Llc | Institution | 3,600,000 | Added More | 76,806 | 2.18 % | $35,748,000 | $37,152,000 | $1,404,000 | 3.92 % | $29,954 | | | | | | News Article | History of Dellacamera Capital Management Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | First Quadrant L P | Institution | 66,700 | No Change | 0 | 0 % | $662,331 | $688,344 | $26,013 | 3.92 % | $0 | | | | | | News Article | History of First Quadrant L P Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Gamco Investors Inc Et Al | Institution | 10,000 | No Change | 0 | 0 % | $99,300 | $103,200 | $3,900 | 3.92 % | $0 | | | | | | News Article | History of Gamco Investors Inc Et Al Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR/A | Ing Investment Management Co | Institution | 18,550 | Added More | 3,200 | 20.84 % | $184,202 | $191,436 | $7,235 | 3.92 % | $1,248 | | | | | | News Article | History of Ing Investment Management Co Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Kbc Group Nv | Institution | 158 | No Change | 0 | 0 % | $1,569 | $1,631 | $62 | 3.92 % | $0 | | | | | | News Article | History of Kbc Group Nv Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Knott David M | Institution | 1,063,435 | Sold Some | -712,627 | -40.12 % | $10,559,910 | $10,974,649 | $414,740 | 3.92 % | $-277,925 | | | | | | News Article | History of Knott David M Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Levin Capital Strategies L P | Institution | 334,737 | Added More | 2,213 | 0.66 % | $3,323,938 | $3,454,486 | $130,547 | 3.92 % | $863 | | | | | | News Article | History of Levin Capital Strategies L P Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Merrill Lynch And Co Inc | Institution | 1,377,897 | Sold Some | -7,850 | -0.56 % | $13,682,517 | $14,219,897 | $537,380 | 3.92 % | $-3,062 | | | | | | News Article | History of Merrill Lynch And Co Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Mfc Global Investment Management Usa Ltd | Institution | 45,758 | Added More | 4,112 | 9.87 % | $454,377 | $472,223 | $17,846 | 3.92 % | $1,604 | | | | | | News Article | History of Mfc Global Investment Management Usa Ltd Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Ii Inc | Institution | 27,180 | Added More | 6,173 | 29.38 % | $269,897 | $280,498 | $10,600 | 3.92 % | $2,407 | | | | | | News Article | History of Padco Advisors Ii Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Padco Advisors Inc | Institution | 181,126 | Added More | 51,942 | 40.20 % | $1,798,581 | $1,869,220 | $70,639 | 3.92 % | $20,257 | | | | | | News Article | History of Padco Advisors Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Placemark Investments Inc | Institution | | Sold All | -15,619 | -100 % | | | | 3.92 % | $-6,091 | | | | | | News Article | History of Placemark Investments Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Royal Bank Of Scotland Group Plc | Institution | 15,000 | New Holding | 15,000 | 100 % | $148,950 | $154,800 | $5,850 | 3.92 % | $5,850 | | | | | | News Article | History of Royal Bank Of Scotland Group Plc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Russell Frank Co | Institution | 7,400 | No Change | 0 | 0 % | $73,482 | $76,368 | $2,886 | 3.92 % | $0 | | | | | | News Article | History of Russell Frank Co Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | San Francisco Sentry Investment Group | Institution | 20,000 | No Change | 0 | 0 % | $198,600 | $206,400 | $7,800 | 3.92 % | $0 | | | | | | News Article | History of San Francisco Sentry Investment Group Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Stafford Asset Management Llc | No Data | 23,750 | Sold Some | -9,250 | -28.03 % | $235,838 | $245,100 | $9,263 | 3.92 % | $-3,608 | | | | | | News Article | History of Stafford Asset Management Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Suntrust Banks Inc | Institution | 289,038 | Sold Some | -3,084 | -1.05 % | $2,870,147 | $2,982,872 | $112,725 | 3.92 % | $-1,203 | | | | | | News Article | History of Suntrust Banks Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Susquehanna International Group Llp | Institution | | Sold All | -9,412 | -100 % | | | | 3.92 % | $-3,671 | | | | | | News Article | History of Susquehanna International Group Llp Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Tewksbury Capital Management Ltd | Institution | | Sold All | -12,183 | -100 % | | | | 3.92 % | $-4,751 | | | | | | News Article | History of Tewksbury Capital Management Ltd Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | United Services Automobile Association | Institution | 74,034 | Sold Some | -24,100 | -24.55 % | $735,158 | $764,031 | $28,873 | 3.92 % | $-9,399 | | | | | | News Article | History of United Services Automobile Association Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-12 | 2009-09-30 | 13F-HR | Virginia Retirement Systems Et Al | Institution | 75,600 | No Change | 0 | 0 % | $750,708 | $780,192 | $29,484 | 3.92 % | $0 | | | | | | News Article | History of Virginia Retirement Systems Et Al Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | American Century Companies Inc | Institution | 68,042 | Sold Some | -1,161 | -1.67 % | $677,018 | $702,193 | $25,176 | 3.71 % | $-430 | | | | | | News Article | History of American Century Companies Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Citigroup Inc | Institution | | Sold All | -10,295 | -100 % | | | | 3.71 % | $-3,809 | | | | | | News Article | History of Citigroup Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | J P Morgan Chase And Co | Institution | 16,748 | New Holding | 16,748 | 100 % | $166,643 | $172,839 | $6,197 | 3.71 % | $6,197 | | | | | | News Article | History of J P Morgan Chase And Co Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Paradigm Capital Management Inc | Institution | 21,935 | No Change | 0 | 0 % | $218,253 | $226,369 | $8,116 | 3.71 % | $0 | | | | | | News Article | History of Paradigm Capital Management Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Tesseract Capital Llc | No Data | 200 | New Holding | 200 | 100 % | $1,990 | $2,064 | $74 | 3.71 % | $74 | | | | | | News Article | History of Tesseract Capital Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ubs Ag | Institution | 1,730,066 | Added More | 7,661 | 0.44 % | $17,214,157 | $17,854,281 | $640,124 | 3.71 % | $2,835 | | | | | | News Article | History of Ubs Ag Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | William Harris Investors Inc | Institution | 150,000 | No Change | 0 | 0 % | $1,492,500 | $1,548,000 | $55,500 | 3.71 % | $0 | | | | | | News Article | History of William Harris Investors Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-10 | 2008-12-31 | 13F-HR/A | Dlibj Asset Management Co Ltd | Institution | | Sold All | -3,200 | -100 % | | | | 3.71 % | $-1,184 | | | | | | News Article | History of Dlibj Asset Management Co Ltd Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Mckinley Capital Management Inc | Institution | 184,473 | New Holding | 184,473 | 100 % | $1,813,370 | $1,903,761 | $90,392 | 4.98 % | $90,392 | | | | | | News Article | History of Mckinley Capital Management Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Missouri Valley Partners Inc | Institution | 75,637 | Added More | 1,843 | 2.49 % | $743,512 | $780,574 | $37,062 | 4.98 % | $903 | | | | | | News Article | History of Missouri Valley Partners Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-09 | 2009-09-30 | 13F-HR | Numeric Investors Llc | Institution | 18,809 | No Change | 0 | 0 % | $184,892 | $194,109 | $9,216 | 4.98 % | $0 | | | | | | News Article | History of Numeric Investors Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Hartford Investment Management Co | Institution | 355,368 | Added More | 48,217 | 15.69 % | $3,191,205 | $3,667,398 | $476,193 | 14.92 % | $64,611 | | | | | | News Article | History of Hartford Investment Management Co Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Metropolitan Life Insurance Co | Institution | 43,157 | No Change | 0 | 0 % | $387,550 | $445,380 | $57,830 | 14.92 % | $0 | | | | | | News Article | History of Metropolitan Life Insurance Co Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pioneer Investment Management Inc | Institution | | Sold All | -138,000 | -100 % | | | | 14.92 % | $-184,920 | | | | | | News Article | History of Pioneer Investment Management Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Pnc Financial Services Group Inc | Institution | 637 | Sold Some | -209 | -24.70 % | $5,720 | $6,574 | $854 | 14.92 % | $-280 | | | | | | News Article | History of Pnc Financial Services Group Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Schwab Charles Investment Management Inc | Institution | 171,701 | Sold Some | -7,199 | -4.02 % | $1,541,875 | $1,771,954 | $230,079 | 14.92 % | $-9,647 | | | | | | News Article | History of Schwab Charles Investment Management Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Teachers Advisors Inc | Institution | 56,347 | Sold Some | -10,506 | -15.71 % | $505,996 | $581,501 | $75,505 | 14.92 % | $-14,078 | | | | | | News Article | History of Teachers Advisors Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-06 | 2009-09-30 | 13F-HR | Tiaa Cref Investment Management Llc | Institution | 252,384 | Sold Some | -12,900 | -4.86 % | $2,266,408 | $2,604,603 | $338,195 | 14.92 % | $-17,286 | | | | | | News Article | History of Tiaa Cref Investment Management Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-06 | 2009-08-31 | N-CSR | John Hancock Funds Ii - All Cap Core Fund | Multi-Cap Core | 37,900 | New Holding | 37,900 | 100 % | $340,342 | $391,128 | $50,786 | 14.92 % | $50,786 | | | | | | News Article | History of John Hancock Funds Ii - All Cap Core Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Parametric Portfolio Associates | Institution | 107,256 | Added More | 6,985 | 6.96 % | $940,635 | $1,106,882 | $166,247 | 17.67 % | $10,827 | | | | | | News Article | History of Parametric Portfolio Associates Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-05 | 2009-09-30 | 13F-HR | Proshare Advisors Llc | Institution | 11,997 | Sold Some | -7,106 | -37.19 % | $105,214 | $123,809 | $18,595 | 17.67 % | $-11,014 | | | | | | News Article | History of Proshare Advisors Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Babson Capital Management Llc | Institution | 31,900 | Sold Some | -868,100 | -96.45 % | $269,555 | $329,208 | $59,653 | 22.13 % | $-1,623,347 | | | | | | News Article | History of Babson Capital Management Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-04 | 2009-09-30 | 13F-HR | Gw Capital Management Incco | Institution | 49,800 | Added More | 100 | 0.20 % | $420,810 | $513,936 | $93,126 | 22.13 % | $187 | | | | | | News Article | History of Gw Capital Management Incco Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSR | Ssga Funds - Ssga Enhanced Small Cap Fund | Small-Cap Core | 11,550 | Sold Some | -2,550 | -18.08 % | $97,598 | $119,196 | $21,599 | 22.13 % | $-4,769 | | | | | | News Article | History of Ssga Funds - Ssga Enhanced Small Cap Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-04 | 2009-08-31 | N-CSR | Ssga Funds - Ssga Small Cap Fund | Small-Cap Core | 3,280 | Sold Some | -320 | -8.88 % | $27,716 | $33,850 | $6,134 | 22.13 % | $-598 | | | | | | News Article | History of Ssga Funds - Ssga Small Cap Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Iridian Asset Management Llc | Institution | 6,782,017 | Sold Some | -1,286,312 | -15.94 % | $57,172,403 | $69,990,415 | $12,818,012 | 22.41 % | $-2,431,130 | | | | | | News Article | History of Iridian Asset Management Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Prudential Financial Inc | Institution | 510,500 | Sold Some | -78,200 | -13.28 % | $4,303,515 | $5,268,360 | $964,845 | 22.41 % | $-147,798 | | | | | | News Article | History of Prudential Financial Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-03 | 2009-09-30 | 13F-HR | Turner Investment Partners Inc | Institution | 64,360 | New Holding | 64,360 | 100 % | $542,555 | $664,195 | $121,640 | 22.41 % | $121,640 | | | | | | News Article | History of Turner Investment Partners Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-11-02 | 2009-08-31 | N-CSRS | Fidelity Select Portfolios - Technology Portfolio | Science & Tech | 115,000 | No Change | 0 | 0 % | $952,200 | $1,186,800 | $234,600 | 24.63 % | $0 | | | | | | News Article | History of Fidelity Select Portfolios - Technology Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-30 | 2009-09-30 | 13F-HR | Oxford Asset Management | Institution | 55,190 | Added More | 9,337 | 20.36 % | $463,044 | $569,561 | $106,517 | 23.00 % | $18,020 | | | | | | News Article | History of Oxford Asset Management Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock | Specialty & Misc | 2,700 | No Compare | | | $22,653 | $27,864 | $5,211 | 23.00 % | | | | | | | News Article | History of Fidelity Commonwealth Trust - Fidelity Nasdaq Composite Index Tracking Stock Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSRS | Fidelity Commonwealth Trust Ii - Fidelity Small Cap Enhanced Index Fund | Small-Cap Core | 16,215 | New Holding | 16,215 | 100 % | $136,044 | $167,339 | $31,295 | 23.00 % | $31,295 | | | | | | News Article | History of Fidelity Commonwealth Trust Ii - Fidelity Small Cap Enhanced Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-Q | Sei Institutional Investments Trust - Siit Large Cap Fund | Large-Cap Core | | Sold All | -11,600 | -100 % | | | | 23.00 % | $-22,388 | | | | | | News Article | History of Sei Institutional Investments Trust - Siit Large Cap Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-30 | 2009-08-31 | N-CSR | Vanguard World Fund - Vanguard Health Care Index Fund | Health/Biotech | 20,496 | New Holding | 20,496 | 100 % | $171,961 | $211,519 | $39,557 | 23.00 % | $39,557 | | | | | | News Article | History of Vanguard World Fund - Vanguard Health Care Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Dimensional Fund Advisors Inc | Institution | 650,364 | Added More | 5,196 | 0.80 % | $5,482,569 | $6,711,756 | $1,229,188 | 22.41 % | $9,820 | | | | | | News Article | History of Dimensional Fund Advisors Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-29 | 2009-09-30 | 13F-HR | Lyz Capital Advisors Llc | Institution | 36,300 | Added More | 20,200 | 125.46 % | $306,009 | $374,616 | $68,607 | 22.41 % | $38,178 | | | | | | News Article | History of Lyz Capital Advisors Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Balanced Strategy Fund | Flexible Portfolio | 44,500 | Sold Some | -10,800 | -19.52 % | $375,135 | $459,240 | $84,105 | 22.41 % | $-20,412 | | | | | | News Article | History of Usaa Mutual Funds Trust - Balanced Strategy Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Cornerstone Strategy Fund | Specialty & Misc | 3,734 | Added More | 1,100 | 41.76 % | $31,478 | $38,535 | $7,057 | 22.41 % | $2,079 | | | | | | News Article | History of Usaa Mutual Funds Trust - Cornerstone Strategy Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | | Sold All | -800 | -100 % | | | | 22.41 % | $-1,512 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-29 | 2009-08-31 | N-Q | Valic Co I - Small Cap Index Fund | Small-Cap Core | 36,676 | New Holding | 36,676 | 100 % | $309,179 | $378,496 | $69,318 | 22.41 % | $69,318 | | | | | | News Article | History of Valic Co I - Small Cap Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-26 | 2009-09-30 | 13F-HR | Schroder Investment Management Group | Institution | 1,100 | No Change | 0 | 0 % | $9,988 | $11,352 | $1,364 | 13.65 % | $0 | | | | | | News Article | History of Schroder Investment Management Group Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-26 | 2009-06-30 | 13F-HR/A | Ameriprise Financial Inc | Institution | 17,040 | Sold Some | -771 | -4.32 % | $154,723 | $175,853 | $21,130 | 13.65 % | $-956 | | | | | | News Article | History of Ameriprise Financial Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Group Ltd | Institution | 14,078 | No Change | 0 | 0 % | $129,095 | $145,285 | $16,190 | 12.54 % | $0 | | | | | | News Article | History of Blackrock Group Ltd Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Inc | No Data | | Sold All | -18,248 | -100 % | | | | 12.54 % | $-20,985 | | | | | | News Article | History of Blackrock Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-22 | 2009-09-30 | 13F-HR | Blackrock Investment Management Llc | Institution | 146,217 | Added More | 31,337 | 27.27 % | $1,340,810 | $1,508,959 | $168,150 | 12.54 % | $36,038 | | | | | | News Article | History of Blackrock Investment Management Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Bank Of New York Mellon Corp | Institution | 251,205 | Sold Some | -1,220,929 | -82.93 % | $2,263,357 | $2,592,436 | $329,079 | 14.53 % | $-1,599,417 | | | | | | News Article | History of Bank Of New York Mellon Corp Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | Fisher Asset Management Llc | Institution | 10,000 | No Change | 0 | 0 % | $90,100 | $103,200 | $13,100 | 14.53 % | $0 | | | | | | News Article | History of Fisher Asset Management Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR/A | Gerry Farber Llc | Institution | 288,000 | Added More | 30,000 | 11.62 % | $2,594,880 | $2,972,160 | $377,280 | 14.53 % | $39,300 | | | | | | News Article | History of Gerry Farber Llc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-21 | 2009-09-30 | 13F-HR | State Board Of Administration Of Florida Retirement System | Institution | 83,736 | Added More | 21,072 | 33.62 % | $754,461 | $864,156 | $109,694 | 14.53 % | $27,604 | | | | | | News Article | History of State Board Of Administration Of Florida Retirement System Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-20 | 2009-09-30 | 13F-HR | Public Employees Retirement Association Of Colorado | Institution | 29,200 | No Change | 0 | 0 % | $263,092 | $301,344 | $38,252 | 14.53 % | $0 | | | | | | News Article | History of Public Employees Retirement Association Of Colorado Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Harris Financial Corp | Institution | 81,890 | Added More | 5,680 | 7.45 % | $748,475 | $845,105 | $96,630 | 12.91 % | $6,702 | | | | | | News Article | History of Harris Financial Corp Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-15 | 2009-09-30 | 13F-HR | Public Employees Retirement System Of Ohio | Institution | 184,664 | No Change | 0 | 0 % | $1,687,829 | $1,905,732 | $217,904 | 12.91 % | $0 | | | | | | News Article | History of Public Employees Retirement System Of Ohio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-14 | 2009-09-30 | 13F-HR | Intrust Bank Na | Institution | 19,792 | Sold Some | -1,138 | -5.43 % | $180,503 | $204,253 | $23,750 | 13.15 % | $-1,366 | | | | | | News Article | History of Intrust Bank Na Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-08 | 2009-09-30 | 13F-HR | Rhumbline Advisers | Institution | 63,466 | Added More | 1,500 | 2.42 % | $543,269 | $654,969 | $111,700 | 20.56 % | $2,640 | | | | | | News Article | History of Rhumbline Advisers Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund | Health/Biotech | 10,800 | Added More | 5,400 | 100.00 % | $94,932 | $111,456 | $16,524 | 17.40 % | $8,262 | | | | | | News Article | History of Fidelity Advisor Series Vii - Fidelity Advisor Biotechnology Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Health Care Ultrasector Profund | Health/Biotech | 146 | Added More | 78 | 114.70 % | $1,283 | $1,507 | $223 | 17.40 % | $119 | | | | | | News Article | History of Profunds - Health Care Ultrasector Profund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-07 | 2009-07-31 | N-CSR | Profunds - Pharmaceuticals Ultrasector Profund | Health/Biotech | 344 | Added More | 264 | 330.00 % | $3,024 | $3,550 | $526 | 17.40 % | $404 | | | | | | News Article | History of Profunds - Pharmaceuticals Ultrasector Profund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-06 | 2009-09-30 | 13F-HR | Franklin Street Advisors Inc | Institution | 306,050 | Sold Some | -26,000 | -7.83 % | $2,662,635 | $3,158,436 | $495,801 | 18.62 % | $-42,120 | | | | | | News Article | History of Franklin Street Advisors Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Growth Fund | Multi-Cap Growth | 800 | New Holding | 800 | 100 % | $6,560 | $8,256 | $1,696 | 25.85 % | $1,696 | | | | | | News Article | History of Usaa Mutual Funds Trust - Growth Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-10-02 | 2009-07-31 | N-CSR | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | | Sold All | -39,600 | -100 % | | | | 25.85 % | $-83,952 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Core Equity Portfolio | International Small-Mid-Cap Value | 57,099 | New Holding | 57,099 | 100 % | $472,780 | $589,262 | $116,482 | 24.63 % | $116,482 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Core Equity Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio | No Data | 13,000 | New Holding | 13,000 | 100 % | $107,640 | $134,160 | $26,520 | 24.63 % | $26,520 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - International Vector Equity Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio | No Data | 400 | No Change | 0 | 0 % | $3,312 | $4,128 | $816 | 24.63 % | $0 | | | | | | News Article | History of Dfa Investment Dimensions Group Inc - Us Sustainability Core 1 Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Dws Balanced Fund - Dws Balanced Fund | Flexible Portfolio | 54,900 | Sold Some | -6,800 | -11.02 % | $454,572 | $566,568 | $111,996 | 24.63 % | $-13,872 | | | | | | News Article | History of Dws Balanced Fund - Dws Balanced Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Jnl Investors Series Trust - Jackson Perspective Index 5 Fund | Specialty & Misc | 805 | No Change | 0 | 0 % | $6,665 | $8,308 | $1,642 | 24.63 % | $0 | | | | | | News Article | History of Jnl Investors Series Trust - Jackson Perspective Index 5 Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-29 | 2009-07-31 | N-Q | Vanguard Explorer Fund - Vanguard Explorer Fund | Small-Cap Growth | | Sold All | -225,100 | -100 % | | | | 24.63 % | $-459,204 | | | | | | News Article | History of Vanguard Explorer Fund - Vanguard Explorer Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Dryden Small Cap Core Equity Fund Inc - Dryden Small Cap Core Equity Fund Inc | Small-Cap Core | 20,500 | New Holding | 20,500 | 100 % | $166,665 | $211,560 | $44,895 | 26.93 % | $44,895 | | | | | | News Article | History of Dryden Small Cap Core Equity Fund Inc - Dryden Small Cap Core Equity Fund Inc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund | Small-Cap Core | 3,410 | Sold Some | -4,960 | -59.25 % | $27,723 | $35,191 | $7,468 | 26.93 % | $-10,862 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Main Street Small Cap Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund | Small-Cap Core | 6,800 | Sold Some | -8,500 | -55.55 % | $55,284 | $70,176 | $14,892 | 26.93 % | $-18,615 | | | | | | News Article | History of Massmutual Premier Funds - Massmutual Premier Small Company Opportunities Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Old Westbury Funds Inc - International Fund | International Multi-Cap Core | 4,900 | No Change | 0 | 0 % | $39,837 | $50,568 | $10,731 | 26.93 % | $0 | | | | | | News Article | History of Old Westbury Funds Inc - International Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dynamic Market Portfolio | Specialty & Misc | 461,322 | Sold Some | -201,471 | -30.39 % | $3,750,548 | $4,760,843 | $1,010,295 | 26.93 % | $-441,221 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dynamic Market Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Powershares Exchange Traded Fund Trust - Powershares Dynamic Small Cap Growth Portfolio | Small-Cap Growth | 13,819 | New Holding | 13,819 | 100 % | $112,348 | $142,612 | $30,264 | 26.93 % | $30,264 | | | | | | News Article | History of Powershares Exchange Traded Fund Trust - Powershares Dynamic Small Cap Growth Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-28 | 2009-07-31 | N-Q | Schwab Capital Trust - Schwab Health Care Fund | Health/Biotech | 50,000 | Added More | 25,000 | 100.00 % | $406,500 | $516,000 | $109,500 | 26.93 % | $54,750 | | | | | | News Article | History of Schwab Capital Trust - Schwab Health Care Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-25 | 2009-07-31 | N-Q | Direxion Shares Etf Trust - Direxion Daily Small Cap Bull 3x Shares | No Data | | Sold All | -23,632 | -100 % | | | | 28.67 % | $-54,354 | | | | | | News Article | History of Direxion Shares Etf Trust - Direxion Daily Small Cap Bull 3x Shares Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-25 | 2009-06-30 | 13F-HR/A | Kbc Group Nv | Institution | 158 | Added More | 48 | 43.63 % | $1,267 | $1,631 | $363 | 28.67 % | $110 | | | | | | News Article | History of Kbc Group Nv Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-24 | 2009-06-30 | 13F-HR/A | Credit Agricole S A | Institution | 8,205 | New Holding | 8,205 | 100 % | $65,722 | $84,676 | $18,954 | 28.83 % | $18,954 | | | | | | News Article | History of Credit Agricole S A Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-17 | 2009-07-31 | N-Q | Rydex Etf Trust - Rydex Inverse Russell 2000 Etf | Specialty & Misc | 970 | New Holding | 970 | 100 % | $7,779 | $10,010 | $2,231 | 28.67 % | $2,231 | | | | | | News Article | History of Rydex Etf Trust - Rydex Inverse Russell 2000 Etf Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 3,129,241 | Added More | 103,569 | 3.42 % | $25,065,220 | $32,293,767 | $7,228,547 | 28.83 % | $239,244 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-11 | 2009-06-30 | 13F-HR/A | Barclays Global Investors Uk Holdings Ltd | Institution | 3,016,676 | Sold Some | -8,996 | -0.29 % | $24,163,575 | $31,132,096 | $6,968,522 | 28.83 % | $-20,781 | | | | | | News Article | History of Barclays Global Investors Uk Holdings Ltd Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-10 | 2009-06-30 | N-CSRS | Northern Lights Variable Trust - Jnf Equity Portfolio | Specialty & Misc | 2,200 | New Holding | 2,200 | 100 % | $17,798 | $22,704 | $4,906 | 27.56 % | $4,906 | | | | | | News Article | History of Northern Lights Variable Trust - Jnf Equity Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Series Funds - Banking Fund | Financial Services | 1,216 | Sold Some | -224 | -15.55 % | $9,412 | $12,549 | $3,137 | 33.33 % | $-578 | | | | | | News Article | History of Rydex Series Funds - Banking Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-08 | 2009-06-30 | N-CSRS | Rydex Variable Trust - Biotechnology Fund | Health/Biotech | 20,107 | Sold Some | -12,790 | -38.87 % | $155,628 | $207,504 | $51,876 | 33.33 % | $-32,998 | | | | | | News Article | History of Rydex Variable Trust - Biotechnology Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Advanced Series Trust - Ast Western Asset Core Plus Bond Portfolio | No Data | | Sold All | -16,500 | -100 % | | | | 32.13 % | $-41,415 | | | | | | News Article | History of Advanced Series Trust - Ast Western Asset Core Plus Bond Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio | Small-Cap Growth | 23,700 | Sold Some | -11,100 | -31.89 % | $185,097 | $244,584 | $59,487 | 32.13 % | $-27,861 | | | | | | News Article | History of Axa Premier Vip Trust - Multimanager Small Cap Growth Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio | Small-Cap Growth | 21,100 | No Change | 0 | 0 % | $164,791 | $217,752 | $52,961 | 32.13 % | $0 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Small Cap Growth Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqalliancebernstein Value Portfolio | Multi-Cap Value | 8,120 | New Holding | 8,120 | 100 % | $63,417 | $83,798 | $20,381 | 32.13 % | $20,381 | | | | | | News Article | History of Eq Advisors Trust - Eqalliancebernstein Value Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Eq Advisors Trust - Eqbond Index Portfolio | Specialty & Misc | 65,390 | Added More | 7,390 | 12.74 % | $510,696 | $674,825 | $164,129 | 32.13 % | $18,549 | | | | | | News Article | History of Eq Advisors Trust - Eqbond Index Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Guidestone Funds - Capital Opportunities | Multi-Cap Core | | Sold All | -32,500 | -100 % | | | | 32.13 % | $-81,575 | | | | | | News Article | History of Guidestone Funds - Capital Opportunities Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Massmutual Select Funds - Massmutual Select Small Company Growth Fund | Small-Cap Growth | 13,060 | Sold Some | -1,180 | -8.28 % | $101,999 | $134,779 | $32,781 | 32.13 % | $-2,962 | | | | | | News Article | History of Massmutual Select Funds - Massmutual Select Small Company Growth Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Bull Profund | Large-Cap Core | | Sold All | -8,742 | -100 % | | | | 32.13 % | $-21,942 | | | | | | News Article | History of Profunds - Bull Profund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Profund Vp Health Care | Health/Biotech | 1,008 | Added More | 412 | 69.12 % | $7,872 | $10,403 | $2,530 | 32.13 % | $1,034 | | | | | | News Article | History of Profunds - Profund Vp Health Care Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Profunds - Profund Vp Pharmaceuticals | Specialty & Misc | 1,872 | Added More | 1,052 | 128.29 % | $14,620 | $19,319 | $4,699 | 32.13 % | $2,641 | | | | | | News Article | History of Profunds - Profund Vp Pharmaceuticals Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund | Small-Cap Core | 13,980 | Sold Some | -2,720 | -16.28 % | $109,184 | $144,274 | $35,090 | 32.13 % | $-6,827 | | | | | | News Article | History of Sun Capital Advisers Trust - Sc Oppenheimer Main Street Small Cap Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Institutional Index Funds - Vanguard Institutional Index Fund | Specialty & Misc | 63,727 | New Holding | 63,727 | 100 % | $497,708 | $657,663 | $159,955 | 32.13 % | $159,955 | | | | | | News Article | History of Vanguard Institutional Index Funds - Vanguard Institutional Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-04 | 2009-06-30 | N-CSRS | Vanguard Variable Insurance Funds - Small Company Growth Portfolio | Small-Cap Growth | 7,500 | New Holding | 7,500 | 100 % | $58,575 | $77,400 | $18,825 | 32.13 % | $18,825 | | | | | | News Article | History of Vanguard Variable Insurance Funds - Small Company Growth Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Jnl Variable Fund Llc - Jnlmcm Healthcare Sector Fund | Health/Biotech | 3 | No Change | 0 | 0 % | $23 | $31 | $8 | 32.81 % | $0 | | | | | | News Article | History of Jnl Variable Fund Llc - Jnlmcm Healthcare Sector Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Mml Series Investment Fund Ii - Mml Small Cap Equity Fund | Small-Cap Core | 12,150 | Added More | 1,840 | 17.84 % | $94,406 | $125,388 | $30,983 | 32.81 % | $4,692 | | | | | | News Article | History of Mml Series Investment Fund Ii - Mml Small Cap Equity Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Pd Small-Cap Growth Index Portfolio | No Data | 781 | No Compare | | | $6,068 | $8,060 | $1,992 | 32.81 % | | | | | | | News Article | History of Pacific Select Fund - Pd Small-Cap Growth Index Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSRS | Pacific Select Fund - Small-Cap Index Portfolio | No Data | 24,004 | New Holding | 24,004 | 100 % | $186,511 | $247,721 | $61,210 | 32.81 % | $61,210 | | | | | | News Article | History of Pacific Select Fund - Small-Cap Index Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-03 | 2009-06-30 | N-CSR | Streettracks Series Trust - Spdr Dividend Etf | Specialty & Misc | | Sold All | -6,370 | -100 % | | | | 32.81 % | $-16,244 | | | | | | News Article | History of Streettracks Series Trust - Spdr Dividend Etf Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Amvescap Plc | Institution | 865,545 | Sold Some | -1,989,675 | -69.68 % | $6,422,344 | $8,932,424 | $2,510,081 | 39.08 % | $-5,770,058 | | | | | | News Article | History of Amvescap Plc Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | 13F-HR/A | Fmr Corp | Institution | 120,400 | No Change | 0 | 0 % | $893,368 | $1,242,528 | $349,160 | 39.08 % | $0 | | | | | | News Article | History of Fmr Corp Ownership Of Enzon Pharmaceuticals Inc |
| 2009-09-01 | 2009-06-30 | N-Q/A | Rydex Series Funds - Biotechnology Fund | Health/Biotech | 127,968 | Added More | 22,967 | 21.87 % | $949,523 | $1,320,630 | $371,107 | 39.08 % | $66,604 | | | | | | News Article | History of Rydex Series Funds - Biotechnology Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Mutual Of America Investment Corp - Bond Fund | Specialty & Misc | 751,813 | Added More | 2,667 | 0.35 % | $5,390,499 | $7,758,710 | $2,368,211 | 43.93 % | $8,401 | | | | | | News Article | History of Mutual Of America Investment Corp - Bond Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Mutual Of America Investment Corp - Equity Index Fund | Specialty & Misc | | Sold All | -440,855 | -100 % | | | | 43.93 % | $-1,388,693 | | | | | | News Article | History of Mutual Of America Investment Corp - Equity Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Northern Lights Fund Trust - Biondo Fund | Health/Biotech | | Sold All | -770 | -100 % | | | | 43.93 % | $-2,426 | | | | | | News Article | History of Northern Lights Fund Trust - Biondo Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Sei Institutional Managed Trust - Large Cap Diversified Alpha Fund | Large-Cap Core | 18,500 | New Holding | 18,500 | 100 % | $132,645 | $190,920 | $58,275 | 43.93 % | $58,275 | | | | | | News Article | History of Sei Institutional Managed Trust - Large Cap Diversified Alpha Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-Q | Sei Institutional Managed Trust - Large Cap Growth Fund | Large-Cap Growth | | Sold All | -13,100 | -100 % | | | | 43.93 % | $-41,265 | | | | | | News Article | History of Sei Institutional Managed Trust - Large Cap Growth Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Tiaa Cref Life Fund - Stock Index Fund | Specialty & Misc | 551 | Added More | 151 | 37.75 % | $3,951 | $5,686 | $1,736 | 43.93 % | $476 | | | | | | News Article | History of Tiaa Cref Life Fund - Stock Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-31 | 2009-06-30 | N-CSRS | Usaa Mutual Funds Trust - Value Fund | Multi-Cap Value | 39,600 | New Holding | 39,600 | 100 % | $283,932 | $408,672 | $124,740 | 43.93 % | $124,740 | | | | | | News Article | History of Usaa Mutual Funds Trust - Value Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-CSRS | Dws Variable Series Ii - Dws Balanced Vip | Flexible Portfolio | 14,400 | Sold Some | -2,600 | -15.29 % | $103,536 | $148,608 | $45,072 | 43.53 % | $-8,138 | | | | | | News Article | History of Dws Variable Series Ii - Dws Balanced Vip Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Nasdaq Biotechnology Index Fund | Health/Biotech | 518,174 | Sold Some | -15,468 | -2.89 % | $3,725,671 | $5,347,556 | $1,621,885 | 43.53 % | $-48,415 | | | | | | News Article | History of Ishares Trust - Ishares Nasdaq Biotechnology Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Growth Index Fund | Multi-Cap Growth | 320,603 | Added More | 16,001 | 5.25 % | $2,305,136 | $3,308,623 | $1,003,487 | 43.53 % | $50,083 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Growth Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 2000 Index Fund | Specialty & Misc | 546,067 | Sold Some | -10,050 | -1.80 % | $3,926,222 | $5,635,411 | $1,709,190 | 43.53 % | $-31,457 | | | | | | News Article | History of Ishares Trust - Ishares Russell 2000 Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Growth Index Fund | Multi-Cap Growth | 2,785 | Sold Some | -315 | -10.16 % | $20,024 | $28,741 | $8,717 | 43.53 % | $-986 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Growth Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell 3000 Index Fund | Specialty & Misc | 11,607 | Added More | 660 | 6.02 % | $83,454 | $119,784 | $36,330 | 43.53 % | $2,066 | | | | | | News Article | History of Ishares Trust - Ishares Russell 3000 Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Ishares Trust - Ishares Russell Microcap Index Fund | Specialty & Misc | 73,370 | Added More | 16,506 | 29.02 % | $527,530 | $757,178 | $229,648 | 43.53 % | $51,664 | | | | | | News Article | History of Ishares Trust - Ishares Russell Microcap Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Seasons Series Trust - Stock Portfolio | Multi-Cap Core | 4,214 | New Holding | 4,214 | 100 % | $30,299 | $43,488 | $13,190 | 43.53 % | $13,190 | | | | | | News Article | History of Seasons Series Trust - Stock Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | N-Q | Sti Classic Funds - Small Cap Growth Stock Fund | Small-Cap Growth | 223,700 | Sold Some | -8,560 | -3.68 % | $1,608,403 | $2,308,584 | $700,181 | 43.53 % | $-26,793 | | | | | | News Article | History of Sti Classic Funds - Small Cap Growth Stock Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-28 | 2009-06-30 | 13F-HR/A | Wells Fargo And Co | Institution | 66,191 | Sold Some | -2,348 | -3.42 % | $475,913 | $683,091 | $207,178 | 43.53 % | $-7,349 | | | | | | News Article | History of Wells Fargo And Co Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Horizon Funds - Vanguard Strategic Equity Fund | Specialty & Misc | 59,835 | New Holding | 59,835 | 100 % | $430,214 | $617,497 | $187,284 | 43.53 % | $187,284 | | | | | | News Article | History of Vanguard Horizon Funds - Vanguard Strategic Equity Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-28 | 2008-06-30 | N-Q | Vanguard Horizon Funds - Vanguard Strategic Small-Cap Equity Fund | Small-Cap Core | 28,600 | New Holding | 28,600 | 100 % | $205,634 | $295,152 | $89,518 | 43.53 % | $89,518 | | | | | | News Article | History of Vanguard Horizon Funds - Vanguard Strategic Small-Cap Equity Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Dws Advisor Funds - Dws Lifecycle Long Range Fund | Mixed-Asset Target Allocation Moderate | 22,100 | New Holding | 22,100 | 100 % | $160,446 | $228,072 | $67,626 | 42.14 % | $67,626 | | | | | | News Article | History of Dws Advisor Funds - Dws Lifecycle Long Range Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Equity Index Fund | Specialty & Misc | 30,629 | Added More | 19,366 | 171.94 % | $222,367 | $316,091 | $93,725 | 42.14 % | $59,260 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Equity Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-Q | Tiaa Cref Institutional Mutual Funds - Growth Equity Fund | Multi-Cap Growth | | Sold All | -15,710 | -100 % | | | | 42.14 % | $-48,073 | | | | | | News Article | History of Tiaa Cref Institutional Mutual Funds - Growth Equity Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Extended Market Index Fund | Mid-Cap Core | 248,271 | Added More | 10,722 | 4.51 % | $1,802,447 | $2,562,157 | $759,709 | 42.14 % | $32,809 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Extended Market Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Growth Index Fund | Large-Cap Growth | 347,618 | New Holding | 347,618 | 100 % | $2,523,707 | $3,587,418 | $1,063,711 | 42.14 % | $1,063,711 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Growth Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-27 | 2009-06-30 | N-CSRS | Vanguard Index Funds - Vanguard Total Stock Market Index Fund | Multi-Cap Core | 477,574 | Added More | 4,100 | 0.86 % | $3,467,187 | $4,928,564 | $1,461,376 | 42.14 % | $12,546 | | | | | | News Article | History of Vanguard Index Funds - Vanguard Total Stock Market Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 27,091 | Added More | 5,000 | 22.63 % | $196,681 | $279,579 | $82,898 | 42.14 % | $15,300 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-27 | 2008-06-30 | N-CSRS | Vanguard Balanced Index Funds - Vanguard Balanced Index Fund | Mixed-Asset Target Allocation Growth | 22,091 | No Change | 0 | 0 % | $160,381 | $227,979 | $67,598 | 42.14 % | $0 | | | | | | News Article | History of Vanguard Balanced Index Funds - Vanguard Balanced Index Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-CSRS | Maxim Series Fund Inc - Maxim Small-Cap Growth Portfolio | No Data | 49,700 | Sold Some | -71,100 | -58.85 % | $363,804 | $512,904 | $149,100 | 40.98 % | $-213,300 | | | | | | News Article | History of Maxim Series Fund Inc - Maxim Small-Cap Growth Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-25 | 2009-06-30 | N-CSRS | Maxim Series Fund Inc - Maxim Small-Cap Value Portfolio | No Data | 36,400 | No Compare | | | $266,448 | $375,648 | $109,200 | 40.98 % | | | | | | | News Article | History of Maxim Series Fund Inc - Maxim Small-Cap Value Portfolio Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-Q | Dreyfus Premier Opportunity Funds - Enterprise Fund | Small-Cap Growth | 27,710 | New Holding | 27,710 | 100 % | $202,283 | $285,967 | $83,684 | 41.36 % | $83,684 | | | | | | News Article | History of Dreyfus Premier Opportunity Funds - Enterprise Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-Q | Mellon Institutional Funds Investment Trust - The Boston Company International Small Cap Fund | Small-Cap Core | | Sold All | -166,260 | -100 % | | | | 41.36 % | $-502,105 | | | | | | News Article | History of Mellon Institutional Funds Investment Trust - The Boston Company International Small Cap Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-Q | Mellon Institutional Funds Investment Trust - The Boston Company Small Cap Growth Fund | Small-Cap Growth | 198,210 | New Holding | 198,210 | 100 % | $1,446,933 | $2,045,527 | $598,594 | 41.36 % | $598,594 | | | | | | News Article | History of Mellon Institutional Funds Investment Trust - The Boston Company Small Cap Growth Fund Ownership Of Enzon Pharmaceuticals Inc |
| 2009-08-24 | 2009-06-30 | N-CSRS | Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva | Specialty & Misc | 70,700 | New Holding | 70,700 | 100 % | $516,110 | $729,624 | $213,514 | 41.36 % | $213,514 | | | | | | News Article | History of Oppenheimer Variable Account Funds - Oppenheimer Main Street Fundva Ownership Of Enzon Pharmaceuticals Inc |
RSS feed for ENZN